Coxsackievirus B3 modulates cell death by downregulating activating transcription factor 3 in HeLa cells

被引:12
|
作者
Hwang, Ha Young
Kim, Joo-Young
Lim, Joong-Yeon
Chung, Sun-Ku
Nam, Jae-Hwan
Park, Sang Ick
机构
[1] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Seoul 122701, South Korea
[2] Catholic Univ, Div Biosci & Technol, Gyeonggi do 420742, South Korea
关键词
coxsackievirus B3; ATF3; p53; apoptosis; virus titer;
D O I
10.1016/j.virusres.2007.05.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Activating transcription factor 3 (ATF3) is an early-induced gene involved in diverse cellular functions in response to various stresses including viral infection. Here we observed marked reduction of ATF3 by coxsackievirus B3 (CVB3) infection and investigated the regulation and functional role of ATF3 in HeLa cells for the understanding of biological significance of ATF3 downregulation. CVB3 infection markedly reduced ATF3 expression at mRNA and protein levels in parallel with p53 degradation, and preservation of p53 expression rescued CVB3 infection-induced ATF3 downregulation. ATF3 overexpression stimulated apoptotic cell death following CVB3 infection, accompanying with augmentation of CVB3 infection-induced eIF2 alpha phosphorylation. However, ATF3 overexpression did not affect viral protein production but promoted virus progeny release. Taken together, our results suggest that ATF3 is under control of p53 in part and that the ATF3 downregulation via p53 degradation may contribute to effective viral production as a modulation mechanism of CVB3 infection-induced cell death. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 50 条
  • [31] Proteome alterations in human host cells infected with coxsackievirus B3
    Rassmann, Alexander
    Henke, Andreas
    Zobawa, Monica
    Carlsohn, Marc
    Saluz, Hans-Peter
    Grabley, Susanne
    Lottspeich, Friedrich
    Munder, Thomas
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 2631 - 2638
  • [32] Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells
    Werner, Bianca
    Dittmann, Sven
    Funke, Carsten
    Ueberla, Klaus
    Piper, Cornelia
    Niehaus, Karsten
    Horstkotte, Dieter
    Farr, Martin
    INFLAMMATION RESEARCH, 2014, 63 (04) : 267 - 276
  • [33] PERINATAL TRANSMISSION OF COXSACKIEVIRUS B3 IN MICE
    MODLIN, JF
    BOWMAN, M
    JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01): : 21 - 25
  • [34] COXSACKIEVIRUS B3 INFECTION OF IMMUNOCOMPROMISED MICE
    HENKE, A
    STELZNER, A
    WHITTON, JL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 283 - 283
  • [35] Seroprevalence of Coxsackievirus B3 in Yantai, China
    Tao, Zexin
    Li, Bo
    Xu, Aiqiang
    Liu, Yao
    Song, Lizhi
    Wang, Suting
    Xiong, Ping
    Lin, Xiaojuan
    Song, Yanyan
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (06) : 537 - 538
  • [36] Autoimmunity in coxsackievirus B3 induced myocarditis
    Huber, SA
    AUTOIMMUNITY, 2006, 39 (01) : 55 - 61
  • [37] Host immune responses to coxsackievirus B3
    Huber, S.
    GROUP B COXSACKIEVIRUSES, 2008, 323 : 199 - 221
  • [38] Genetic determinants of coxsackievirus B3 pathogenesis
    McManus, BM
    Yanagawa, B
    Rezai, N
    Luo, HL
    Taylor, L
    Zhang, M
    Yuan, J
    Buckley, J
    Triche, T
    Schreiner, G
    Yang, DC
    MICROARRAYS, IMMUNE RESPONSES AND VACCINES, 2002, 975 : 169 - 179
  • [39] Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis
    Kishimoto C.
    Kuroki Y.
    Kurokawa M.
    Ohiai H.
    Basic Research in Cardiology, 1997, 92 (6) : 402 - 409
  • [40] Susceptibility of human bone marrow cells and hematopoietic cell lines to coxsackievirus B3 infection
    Vuorinen, T
    Vainionpaa, R
    Vanharanta, R
    Hyypia, T
    JOURNAL OF VIROLOGY, 1996, 70 (12) : 9018 - 9023